GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jamjoom Pharmaceuticals Factory Co (SAU:4015) » Definitions » Net Income

Jamjoom Pharmaceuticals Factory Co (SAU:4015) Net Income : ﷼349 Mil (TTM As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Jamjoom Pharmaceuticals Factory Co Net Income?

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. Jamjoom Pharmaceuticals Factory Co's Net Income for the three months ended in Sep. 2024 was ﷼95 Mil. Its Net Income for the trailing twelve months (TTM) ended in Sep. 2024 was ﷼349 Mil.

Net Income is linked to the most popular Earnings per Share (Diluted) number. Jamjoom Pharmaceuticals Factory Co's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was ﷼1.36.


Jamjoom Pharmaceuticals Factory Co Net Income Historical Data

The historical data trend for Jamjoom Pharmaceuticals Factory Co's Net Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jamjoom Pharmaceuticals Factory Co Net Income Chart

Jamjoom Pharmaceuticals Factory Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Net Income
206.86 170.70 171.31 292.40

Jamjoom Pharmaceuticals Factory Co Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 77.25 44.48 102.97 106.95 94.99

Jamjoom Pharmaceuticals Factory Co Net Income Calculation

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.

Net Income
= Revenue - Cost of Goods Sold - Selling, General, & Admin. Expense - Research & Development - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= EBITDA - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Operating Income - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others

Jamjoom Pharmaceuticals Factory Co's Net Income for the fiscal year that ended in Dec. 2023 is calculated as

Net Income(A: Dec. 2023 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=315.799+-23.399+0+0
=292

Jamjoom Pharmaceuticals Factory Co's Net Income for the quarter that ended in Sep. 2024 is calculated as

Net Income(Q: Sep. 2024 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=101.263+-6.27+0+-1.4210854715202E-14
=95

Net Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼349 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jamjoom Pharmaceuticals Factory Co  (SAU:4015) Net Income Explanation

Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:

Jamjoom Pharmaceuticals Factory Co's Earnings per Share (Diluted) (EPS) for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

EPS is most useful for companies that have:

A predictable business
Consistent accounting methods
And few restructurings

The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Jamjoom Pharmaceuticals Factory Co Net Income Related Terms

Thank you for viewing the detailed overview of Jamjoom Pharmaceuticals Factory Co's Net Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Jamjoom Pharmaceuticals Factory Co Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box No. 6267, Jeddah, SAU, 21442
Jamjoom Pharmaceuticals Factory Co is engaged in the development, manufacture, and marketing of a wide range of high-quality branded generic pharmaceuticals, including pharmaceuticals and consumer health products, with the majority of revenue coming from pharmaceutical sales. Geographically the company has a presence in the Kingdom of Saudi Arabia, the Gulf, Iraq, Egypt, North Africa, and other export markets.

Jamjoom Pharmaceuticals Factory Co Headlines

No Headlines